A detailed history of Sound Income Strategies, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Sound Income Strategies, LLC holds 1 shares of EXEL stock, worth $35. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 1 -0.0%
Holding current value
$35
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021

SELL
$16.3 - $21.14 $130 - $169
-8 Reduced 88.89%
1 $0
Q2 2021

Jul 13, 2021

BUY
$17.95 - $25.56 $17 - $25
1 Added 12.5%
9 $0
Q4 2019

Jan 07, 2020

BUY
$15.15 - $18.89 $121 - $151
8 New
8 $0
Q4 2019

Jan 06, 2020

SELL
$15.15 - $18.89 $7,696 - $9,596
-508 Closed
0 $0
Q3 2019

Oct 04, 2019

SELL
$17.68 - $22.65 $3,536 - $4,530
-200 Reduced 28.25%
508 $9,000
Q1 2019

Apr 04, 2019

BUY
$19.6 - $24.76 $13,720 - $17,332
700 Added 8750.0%
708 $17,000
Q4 2017

Feb 14, 2018

BUY
$24.23 - $30.93 $193 - $247
8
8 $0

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.6B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.